Cytochrome P450 (CYP) enzymes have long been associated with drug metabolism. But new research suggests CYP4A may be a good candidate for treating hypertension. Last week, researchers reported in the Proceedings of the National Academy Sciences that a disruption in a CYP4A gene in mice resulted in hypertension with increased severity in males versus females, a common feature of the disease.